Truist Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Buy |
9,104
+252
| +3% | +$16.4K | ﹤0.01% | 1858 |
|
|
2025
Q1 | $625K | Sell |
8,852
-2,394
| -21% | -$169K | ﹤0.01% | 1736 |
|
|
2024
Q4 | $739K | Buy |
11,246
+3,576
| +47% | +$235K | ﹤0.01% | 1682 |
|
|
2024
Q3 | $542K | Buy |
7,670
+1,355
| +21% | +$95.7K | ﹤0.01% | 1805 |
|
|
2024
Q2 | $419K | Sell |
6,315
-989
| -14% | -$65.6K | ﹤0.01% | 2072 |
|
|
2024
Q1 | $496K | Sell |
7,304
-6,805
| -48% | -$462K | ﹤0.01% | 1964 |
|
|
2023
Q4 | $872K | Buy |
14,109
+159
| +1% | +$9.83K | ﹤0.01% | 1664 |
|
|
2023
Q3 | $823K | Sell |
13,950
-231
| -2% | -$13.6K | ﹤0.01% | 1646 |
|
|
2023
Q2 | $847K | Sell |
14,181
-1,128
| -7% | -$67.4K | ﹤0.01% | 1662 |
|
|
2023
Q1 | $895K | Buy |
15,309
+5,139
| +51% | +$300K | ﹤0.01% | 1613 |
|
|
2022
Q4 | $631K | Buy |
10,170
+6
| +0.1% | +$372 | ﹤0.01% | 1791 |
|
|
2022
Q3 | $575K | Buy |
10,164
+306
| +3% | +$17.3K | ﹤0.01% | 1744 |
|
|
2022
Q2 | $630K | Buy |
9,858
+468
| +5% | +$29.9K | ﹤0.01% | 1763 |
|
|
2022
Q1 | $608K | Sell |
9,390
-81
| -0.9% | -$5.25K | ﹤0.01% | 1880 |
|
|
2021
Q4 | $631K | Sell |
9,471
-9,654
| -50% | -$643K | ﹤0.01% | 1873 |
|
|
2021
Q3 | $1.17M | Buy |
19,125
+879
| +5% | +$53.6K | ﹤0.01% | 1507 |
|
|
2021
Q2 | $1.13M | Sell |
18,246
-3,345
| -15% | -$207K | ﹤0.01% | 1559 |
|
|
2021
Q1 | $1.28M | Sell |
21,591
-105
| -0.5% | -$6.22K | ﹤0.01% | 1440 |
|
|
2020
Q4 | $1.3M | Buy |
21,696
+2,478
| +13% | +$148K | ﹤0.01% | 1349 |
|
|
2020
Q3 | $1.05M | Buy |
19,218
+4,137
| +27% | +$226K | ﹤0.01% | 1339 |
|
|
2020
Q2 | $773K | Sell |
15,081
-768
| -5% | -$39.4K | ﹤0.01% | 1400 |
|
|
2020
Q1 | $711K | Buy |
15,849
+822
| +5% | +$36.9K | ﹤0.01% | 1384 |
|
|
2019
Q4 | $802K | Buy |
+15,027
| New | +$802K | ﹤0.01% | 1543 |
|